ℹ️ Click the thumbnail image above to view or download the high-resolution poster PDF.
This poster is presented at SITC 2023 San Diego & the 10th Digital Pathology & AI Congress Europe, and created in collaboration with Akoya Biosciences.
Objective:
The study demonstrates the use of integrated spatial multiplexed imaging technologies and data analysis to phenotype the tumor microenvironment (TME) effectively from discovery to clinical application.
Process:
- High-complexity profiling of human cancer tissues was performed using Akoya Biosciences, Inc. PhenoCode Discovery panels on the PhenoCycler®-Fusion platform.
- Key biomarkers identified in the discovery phase were targeted in high-throughput experiments using PhenoCode™ Signature panels on the PhenoImager® HT platform.
Analysis:
- We utilized Visiopharm’s deep learning algorithms for image analysis.
- We conducted specific tissue region segmentation and accurate cell detection and classification.
- We investigated spatial interactions among cell types through spatial neighborhood analysis.
Goal:
The workflow aims to bridge the gap between ultrahigh-plex discovery experiments and targeted high-throughput translational and clinical studies, ensuring successful clinical adoption of predictive spatial biomarkers for immunotherapy response.
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more
You might also like these Posters:
Analysis of the contribution of macrophages to the overall tumor PD-L1 microenvironment using a screening multi-tumor tissue microarray and rapid multiplex fluorescence digital phenotyping approach
OracleBio analysis data is presented at at American Society of Clinical Oncology (ASCO) in June 2022. The poster, presented by Marie Cumberbatch from TriStar Technology Group, is collaborative work between TriStar, Ultivue, and OracleBio. The work involved multiplex...
Utilizing Quantitative Digital Pathology techniques for analysis of Hepatitis B liver samples stained with a 12-plex multiplex-IF assay
OracleBio data is presented at the 8th Digital Pathology & AI Congress: USA 2022 in New York. The poster, produced in collaboration with Gilead, involved a comprehensive evaluation of Hepatitis B liver samples stained using a 12-plex assay, with this poster...
A Quantitative Digital Pathology Workflow to Manage Technical Challenges within Multiplex IF R&D Studies
This poster, created in collaboration with Bristol Myers Squibb, details OracleBio's robust image analysis workflow in Indica Labs HALO, and how it helped overcome common technical issues encountered in a large multiplex IF (mIF) non-small cell lung cancer (NSCLC)...
